Published Sep 20, 2026
Phio Pharmaceuticals (PHIO): Skin Cancer Gene Silencing Trades Below Cash
In-depth research on PHIO covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.
3,961 words18 min read
Read report